Explore the words cloud of the PLASREVOLUTION project. It provides you a very rough idea of what is the project "PLASREVOLUTION" about.
The following table provides information about the project.
Coordinator |
SERVICIO MADRILENO DE SALUD
Organization address contact info |
Coordinator Country | Spain [ES] |
Total cost | 1˙497˙314 € |
EC max contribution | 1˙497˙314 € (100%) |
Programme |
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC)) |
Code Call | ERC-2017-STG |
Funding Scheme | ERC-STG |
Starting year | 2018 |
Duration (year-month-day) | from 2018-02-01 to 2023-01-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | SERVICIO MADRILENO DE SALUD | ES (MADRID) | coordinator | 1˙497˙314.00 |
Antibiotics are essential tools in modern medicine and are indispensable not only for the treatment of infectious diseases but also to support other key interventions such as surgery and cancer chemotherapy. However, the extensive and inappropriate use of antibiotics has fuelled the spread of resistance mechanisms in pathogenic bacteria, leading to the dawn of a post-antibiotic era. Plasmids play a pivotal role in the evolution of antibiotic resistance (AR) because they drive the horizontal transfer of resistance genes between pathogenic bacteria by conjugation. Some of these plasmid-bacterium associations become particularly successful, creating superbugs that spread uncontrollably in clinical settings. The rise of these clones is mainly constricted because plasmids entail a fitness cost when they arrive in a new bacterial host. This cost can be subsequently alleviated through compensatory adaptation during plasmid-bacterium coevolution. Despite the importance of this cost-compensation dynamic in the evolution of plasmid-mediated AR, it remains completely unexplored in clinical contexts. In this project I plan to bridge this gap by exploring the genetic basis underlying the evolution of plasmid-mediated AR in clinically relevant scenarios. We will study, for the first time, the intra-patient transmission, fitness cost and adaptation of AR plasmids in the gut microbiome of hospitalized patients (obj. 1). We will analyse the molecular mechanisms that determine the success of AR plasmids and bacterial clone associations (obj. 2). Finally, we will develop new technology to test how antibiotic treatments affect AR plasmids dynamics in the gut microbiome at an unprecedentedly high-resolution (obj. 3). This ground-breaking project will allow a new understanding of the evolution of plasmid-mediated AR in real life, opening new research avenues and providing a major step towards meeting one of the central challenges facing our society: controlling the spread of AR.
year | authors and title | journal | last update |
---|---|---|---|
2019 |
R. Craig MacLean, Alvaro San Millan The evolution of antibiotic resistance published pages: 1082-1083, ISSN: 0036-8075, DOI: 10.1126/science.aax3879 |
Science 365/6458 | 2019-10-03 |
2018 |
Alvaro San Millan Evolution of Plasmid-Mediated Antibiotic Resistance in the Clinical Context published pages: , ISSN: 0966-842X, DOI: 10.1016/j.tim.2018.06.007 |
Trends in Microbiology monthly | 2019-06-11 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLASREVOLUTION" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PLASREVOLUTION" are provided by the European Opendata Portal: CORDIS opendata.